# LPAR2

## Overview
LPAR2, or lysophosphatidic acid receptor 2, is a gene that encodes a G protein-coupled receptor involved in various physiological and pathological processes. The receptor, lysophosphatidic acid receptor 2, is primarily located in the cell membrane and is activated by lysophosphatidic acid (LPA), a lipid signaling molecule. This activation initiates a cascade of intracellular signaling pathways that regulate cell survival, proliferation, and migration. LPAR2 is expressed in multiple tissues and plays a crucial role in the nervous system, gastrointestinal tract, and immune responses. It is also implicated in several diseases, including cancer and neurodegenerative disorders, highlighting its significance in both normal cellular function and disease pathogenesis (Geraldo2021Role; Birgbauer2020Lysophosphatidic; Hutka2023A).

## Function
LPAR2, or lysophosphatidic acid receptor 2, is a G protein-coupled receptor that plays a significant role in various cellular processes, including cell survival, proliferation, and migration. It is primarily active in the cell membrane, where it binds lysophosphatidic acid (LPA), a bioactive lipid mediator. This interaction triggers several downstream signaling pathways involving G proteins such as Gαi, Gαq, and Gα12/13, which subsequently activate Ras and Rac GTPases, phosphatidylinositol 3-kinase (PI3K), MAPK, and phospholipase C gamma (PLCγ) (Geraldo2021Role; Birgbauer2020Lysophosphatidic).

In healthy human cells, LPAR2 is involved in maintaining cellular homeostasis and promoting cell survival. It is expressed in various tissues and contributes to nervous system development and function, including myelination and immune responses (Geraldo2021Role). LPAR2 also plays a role in the gastrointestinal tract, where it activates prosurvival signaling pathways in intestinal epithelial cells, protecting against apoptosis and maintaining mucosal integrity (Hutka2023A). Additionally, LPAR2 is implicated in brain development, influencing processes such as neuronal migration and neuron-glia interactions, which are crucial for cortical neurogenesis (Geraldo2021Role).

## Clinical Significance
Alterations in the expression or function of the LPAR2 gene have been implicated in several diseases. In the context of nonsteroidal anti-inflammatory drug (NSAID)-induced enteropathy, LPAR2 plays a dual role by maintaining mucosal integrity and contributing to inflammation. The deletion or silencing of LPAR2 results in less severe colitis, indicating its involvement in immune cell activation and migration. NSAIDs like indomethacin reduce LPAR2 expression, which may be an early event in NSAID-induced enteropathy and could be linked to the anticancer effects of NSAIDs, as increased LPAR2 activity is associated with tumorigenesis (Hutka2023A).

In amyotrophic lateral sclerosis (ALS), LPAR2 expression is increased in both human and mouse models. Genetic deletion of LPAR2 in ALS mice delayed disease onset and slowed neurological decline, although it unexpectedly shortened lifespan, suggesting a complex role in disease progression and survival (PuigdomenechPoch2021Dual).

In cancer, LPAR2 is overexpressed in endometrial and colorectal cancers, where it is associated with increased cell proliferation, migration, and invasion. Its expression correlates with clinical features such as tumor stage and depth of invasion, indicating its potential as a biomarker for cancer progression (Geraldo2021Role; WASNIEWSKI2015The).

## Interactions
Lysophosphatidic acid receptor 2 (LPAR2) is a G protein-coupled receptor that engages in various protein-protein interactions, influencing multiple cellular processes. LPAR2 contains two distinct protein-protein interaction domains in its carboxyl-terminal tail, which facilitate its association with several proteins. In the proximal region, LPAR2 has a di-leucine motif and putative palmitoylated cysteine residues that interact with zinc-finger proteins, including TRIP6 and the pro-apoptotic Siva-1 protein (Knowlden2013LPAR2). The distal region of LPAR2 features a class I PDZ-binding motif, which mediates interactions with proteins such as Na+/H+ exchanger regulatory factor 2 (NHERF2), PDZ-RhoGEF, LARG, and MAGI-3 (Knowlden2013LPAR2).

LPAR2 also couples with and activates three heterotrimeric G proteins: Gi, Gq, and G12/13, which transmit signals through downstream molecules like phosphatidylinositol 3-kinase, phospholipase C, Ras, Rac, and Rho (Knowlden2013LPAR2). These interactions are crucial for LPAR2's role in cell survival, differentiation, migration, and cancer metastasis. LPAR2 recruits TRIP6 to the plasma membrane, promoting cell migration, while the PTPL1 phosphatase dephosphorylates TRIP6, attenuating LPA-induced cell migration (Knowlden2013LPAR2). These interactions highlight LPAR2's involvement in complex signaling networks that regulate various cellular functions.


## References


[1. (Knowlden2013LPAR2) S Knowlden and S Georas. Lpar2 (lysophosphatidic acid receptor 2). Atlas of Genetics and Cytogenetics in Oncology and Haematology, April 2013. URL: http://dx.doi.org/10.4267/2042/48867, doi:10.4267/2042/48867. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.4267/2042/48867)

[2. (Birgbauer2020Lysophosphatidic) Eric Birgbauer. Lysophosphatidic acid signalling in nervous system development and function. NeuroMolecular Medicine, 23(1):68–85, November 2020. URL: http://dx.doi.org/10.1007/s12017-020-08630-2, doi:10.1007/s12017-020-08630-2. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12017-020-08630-2)

[3. (Hutka2023A) Barbara Hutka, Anett Várallyay, Szilvia B. László, András S. Tóth, Bálint Scheich, Sándor Paku, Imre Vörös, Zoltán Pós, Zoltán V. Varga, Derek D. Norman, Andrea Balogh, Zoltán Benyó, Gábor Tigyi, Klára Gyires, and Zoltán S. Zádori. A dual role of lysophosphatidic acid type 2 receptor (lpar2) in nonsteroidal anti-inflammatory drug-induced mouse enteropathy. Acta Pharmacologica Sinica, 45(2):339–353, October 2023. URL: http://dx.doi.org/10.1038/s41401-023-01175-7, doi:10.1038/s41401-023-01175-7. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41401-023-01175-7)

[4. (PuigdomenechPoch2021Dual) Maria Puigdomenech-Poch, Anna Martínez-Muriana, Pol Andrés-Benito, Isidre Ferrer, Jerold Chun, and Rubèn López-Vales. Dual role of lysophosphatidic acid receptor 2 (lpa2) in amyotrophic lateral sclerosis. Frontiers in Cellular Neuroscience, March 2021. URL: http://dx.doi.org/10.3389/fncel.2021.600872, doi:10.3389/fncel.2021.600872. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fncel.2021.600872)

[5. (WASNIEWSKI2015The) TOMASZ WASNIEWSKI, IZABELA WOCLAWEK-POTOCKA, DOROTA BORUSZEWSKA, ILONA KOWALCZYK-ZIEBA, EMILIA SINDEREWICZ, and KATARZYNA GRYCMACHER. The significance of the altered expression of lysophosphatidic acid receptors, autotaxin and phospholipase a2 as the potential biomarkers in type 1 endometrial cancer biology. Oncology Reports, 34(5):2760–2767, August 2015. URL: http://dx.doi.org/10.3892/or.2015.4216, doi:10.3892/or.2015.4216. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or.2015.4216)

[6. (Geraldo2021Role) Luiz Henrique Medeiros Geraldo, Tânia Cristina Leite de Sampaio Spohr, Rackele Ferreira do Amaral, Anna Carolina Carvalho da Fonseca, Celina Garcia, Fabio de Almeida Mendes, Catarina Freitas, Marcos Fabio dosSantos, and Flavia Regina Souza Lima. Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies. Signal Transduction and Targeted Therapy, February 2021. URL: http://dx.doi.org/10.1038/s41392-020-00367-5, doi:10.1038/s41392-020-00367-5. This article has 145 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41392-020-00367-5)